USC Breast Cancer Research
Did you know that you could be the difference in a breast cancer patient’s life?
By supporting translational research that could identify cancer cells that possess the ability to metastasize, your support could mean that physicians could personalize treatment for those patients using only a simple blood test.
Dr. Julie Lang, a USC breast cancer surgeon-scientist thinks that her team might be close to bringing this research to reality.
But with only 5-10% of research grants written by university professors funded, there are a lot of good ideas for cancer research that are inadequately supported by traditional research grants. Today, you have the opportunity to be the difference by directly supporting Dr. Lang’s leading cancer research.
Dr. Lang’s laboratory studies circulating tumor cells (CTCs), rare cells that are shed by the primary tumor into the bloodstream of breast cancer patients. CTCs are tumor cells that possess the ability to metastasize, a characteristic that most primary tumor cells lack. The laboratory can isolate these rare cancer cells from the blood of breast cancer patients in order to analyze the biology of these cells. This novel approach permits a liquid biopsy of the status of tumor biology that can hopefully be used in the future to determine opportunities for better treating cancers based on a simple blood test. The Lang laboratory is a leader in this field based on their expertise with rare cell analysis.
Imagine the peace of mind that would come with knowing that by identifying circulating tumor cells early, the risk of metastasizing could be reduced or even eliminated by personalized treatment. When you make a gift you are making a real impact on mothers, daughters, sisters and wives. Funds raised to support Dr. Lang today will directly benefit research to create a world without cancer tomorrow.
Join Dr. Lang in Making the Difference in Breast Cancer Care.
Help Save a Life Tomorrow by Giving Today.